Delivery Order SPE2DB22D1041-SPE2DB24FUCL7
Award Date
7/5/24
Potential Completion Date
7/8/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to deliver REXULTI 2 MG TABLET 30S to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,334.78 and a completion date of January 14, 2025. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $9,179.99 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as...
This federal contract award is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and Veterans Affairs (VA). The contract is a Delivery Order with a Firm Fixed Price of $5,810.14 and an ultimate completion date of April 22, 2024....
This federal contract award is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $3,478.90, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of November 19, 2024. The contract is not designated with a set-aside requirement, indicating open...
This federal contract award is for the delivery of REXULTI 2 MG TABLET 30S to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD). The contract, valued at $5,725.72, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 20, 2024, with a completion date of June 21, 2024. The contract is a Delivery Order, with a Firm Fixed Price pricing structure. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp's...
This federal contract award is for the delivery of REXULTI 2 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,420.21, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award is for the delivery of REXULTI 1 MG Tablets in quantities of 30's, awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,192.98 Delivery Order contract has a firm fixed price, with a period of performance through July 1, 2024. The contracting agency is the Defense Logistics Agency (DLA), a defense agency of the U.S. Department of Defense. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of REXULTI 3 MG TABLET 30S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 8, 2024 with a completion date of March 11, 2024. The contract has a firm fixed-price ceiling value of $39,575.06. This appears to be a delivery order against a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
This federal contract award is for the delivery of REXULTI 0.5 MG TABLET 30S pharmaceutical products to the Defense Logistics Agency (DLA). The $6,034.90 firm-fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of May 11, 2023 and was awarded on May 10, 2023. This contract is not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,705.82 firm-fixed-price delivery order is for the provision of REXULTI 1 MG TABLET 30S, a pharmaceutical product. The award has a completion date of February 21, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...